Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01558518 · ClinicalTrials.gov registry record

Handheld Echocardiography in Clinical Practice

A clinical trial of Cardiovascular Disease, sponsored by Mayo Clinic.

Completed
Registry status
200
Enrollment target
1
Study location

NCT01558518: Completed study of Cardiovascular Disease, sponsored by Mayo Clinic.

NCT01558518 is a study of Cardiovascular Disease that has completed, run by Mayo Clinic. The registered enrollment target is 200 participants, below the 2,696-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01558518, a study of Cardiovascular Disease, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
200 participants
Enrollment target
1
Study location

Study Summary

Transthoracic echocardiography (TTE) represents an established and fundamental tool for the evaluation of patients with known or suspected cardiovascular disease. Recently, manufacturers have developed handheld echocardiograms small enough to fit in the pocket of a physician's lab coat. Studies assessing these handheld devices have several limitations. While they have generally evaluated the handheld devices favorably, previous studies has not consistently studied handheld devices under the best possible clinical conditions and have not necessarily highlighted the devices' limitations. In this proposal, we seek to analyze the applicability of handheld echocardiograms to standard clinical practice. The investigators plan to use trained sonographers to perform handheld examinations on patients referred for TTE without established cardiovascular disease. The handheld images will be interpreted by experienced, consultant-level echocardiographers. The investigators then plan to compare findings from the handheld echocardiogram to the patient's standard clinical TTE.

Conditions Studied

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2012-09
Est. Completion 2013-07
Mayo Clinic

2,844 total trials

What the finished NCT01558518 record still lists

NCT01558518 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 2,696-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Cardiovascular Disease appearing as the primary indexed condition, and to 0 interventions.

NCT01558518 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT01558518 about?

NCT01558518 is a clinical study titled "Handheld Echocardiography in Clinical Practice". Transthoracic echocardiography (TTE) represents an established and fundamental tool for the evaluation of patients with known or suspected cardiovascular disease. Recently, manufacturers have developed handheld echocardiograms small enough to fit in the pocket of a physician's lab coat. Studies asse...

What is the current status of trial NCT01558518?

This trial is currently completed. The enrollment target is 200 participants. The study started on 2012-09. Estimated completion is 2013-07.

What conditions does trial NCT01558518 study?

This clinical trial studies the following conditions: Cardiovascular Disease.

Who is sponsoring clinical trial NCT01558518?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01558518 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01558518's enrollment target sits among peer trials

200 49th of 137 higher than 87 of 137 other Cardiovascular Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiovascular Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01558518, the US trial registry maintained by the National Library of Medicine. NCT01558518 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.